TABLE 1

Patient Characteristics and Imaging Findings

Patient no.Age (y)Diagnosis18F-fluorocholine PET/CT–positive tumor lesionsBAY 864367 PET/CT findings
167PCa, ID 01/2010—Tumor activity, left peripheral prostate (SUVmax, 2.4)
279PCa, ID 04/2010Suggestive of central PCaSuggestive of central PCa (SUVmax, 13.1)
363PCa, ID 04/2010Suggestive of PCa, apical right; no clear evidence of LN metSuggestive of PCa, apical right; no clear evidence of LN met (SUVmax, 11.8)
474PCa, ID 07/2010PCa bilaterally peripheral, no LNNo focal radionuclide uptake
567PCa, ID 07/2010Suggestive of PCa, both lobesNo focal radionuclide uptake
677PCa, ID 01/2007; rP; prostate-specific antigen rec 06/2009Local rec dorsal of left ureter (1.2 cm) (SUVmax early and late, 1.7)No focal radionuclide uptake
760PCa, ID 11/1996; rP; prostate-specific antigen rec 08/2008Local rec in prostate compartment (SUVmax early, 5.0; SUVmax late, 5.6)No focal radionuclide uptake
868PCa, ID 09/2007; rP; prostate-specific antigen rec 01/2010Osteosclerotic met in fourth rib, left sideMinimal local osseous activity in left lateral fourth rib (SUVmax, 2.8)
964PCa, ID 02/1999; rPSuggestive of bone met, th5 and th6 (which could not be proven on follow-up choline PET)Lesion dorsal to right external iliac vein below bifurcation, with maximal diameter of 11 mm (SUVmax, 13.2)
1075PCa, ID 2004, radiation therapy; prostate-specific antigen rec 09/2007Multiple bone and LN metNo focal radionuclide uptake
  • ID = initial diagnosis; LN = lymph node; rP = radical prostatectomy; rec = recurrence; met = metastases; th = thoracic vertebra.